Breakthroughs in cell-penetrating monoclonal antibody therapies
“Monoclonal antibodies (mAb) have emerged as a promising tool in advancing personalized medicine”
2024-12-11
(Press-News.org)
“Monoclonal antibodies (mAb) have emerged as a promising tool in advancing personalized medicine.”
BUFFALO, NY – December 11, 2024 – A news feature on the research paper “Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition” by Rackear et al. was published in Oncotarget’s Volume 15 on November 22, 2024, titled “Advancements in cell-penetrating monoclonal antibody treatment.“
This new publication by Sai Pallavi Pradeep and Raman Bahal from the Department of Pharmaceutical Sciences at the University of Connecticut highlights significant advancements in monoclonal antibody (mAb) therapies. The focus is on the 3E10 antibody, originally derived from autoimmune mouse studies in systemic lupus erythematosus. Unlike traditional mAbs, which struggle to reach intracellular targets, this cell-penetrating antibody targets cancer cells by addressing a major limitation of current therapies. By targeting RAD51, a key intracellular protein involved in DNA repair, the 3E10 antibody shows great promise for cancer treatment, particularly in cancers with defective DNA repair pathways.
mAbs have already changed the landscape of cancer therapy, offering treatments that are more targeted and have fewer side effects compared to chemotherapy. However, current therapies are limited since mAbs only target proteins on the surface of cancer cells. This research pushes the boundaries by demonstrating how 3E10 antibodies can penetrate cells and access their internal molecules. This unique capability expands the potential of mAb therapies and targeted cancer treatments.
Different humanized versions of the 3E10 antibody were created and carefully tested. Some versions were particularly effective at blocking RAD51, while others showed promise for carrying other therapeutic molecules like genetic material into the cancer cells. This flexibility means that 3E10 could be used to treat different cancer types and deliver various therapeutic molecules directly into tumor cells. This progress offers exciting new possibilities for treating cancer tumors that are resistant to conventional therapies.
In conclusion, the 3E10 antibody’s dual function—targeting DNA repair pathways and delivering therapeutic molecules—positions it as a transformative tool in cancer research and targeted cancer treatments.
Continue reading: DOI: https://doi.org/10.18632/oncotarget.28674
Correspondence to: Raman Bahal – raman.bahal@uconn.edu
Keywords: cancer, monoclonal anti-bodies, cell penetration, nucleic acid delivery, 3E10
Click here to sign up for free Altmetric alerts about this article.
About Oncotarget:
Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
X
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker St., Suite 1
Orchard Park, NY 14127
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2024-12-11
“These initial results suggest that individuals with SCD have a significantly higher cellular senescence burden which may contribute to premature aging, physiological decline, and excess morbidities.”
BUFFALO, NY- December 11, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 21 on November 14, 2024, entitled, “Adolescents and young adults with sickle cell disease exhibit accelerated aging with elevated T-cell p16INK4a expression.”
Researchers Samuel R. Wilson, Natalia Mitin, ...
2024-12-11
One of the great ambitions in the scientific world is to use tiny objects—such as molecules, viruses, and nanoparticles—as building blocks to construct essential macromolecules and materials, much like constructing intricate designs with LEGO bricks. However, achieving this requires overcoming significant challenges. Molecules in liquid environments move randomly and at extraordinary speeds—approximately many times faster than Usain Bolt at peak velocity—making precise manipulation extraordinarily challenging.
To ...
2024-12-11
Advancing the energy transition requires more than just technological innovation – it demands a joint effort between public and private actors. Giovanna Pinilla De La Cruz’s doctoral dissertation at the University of Vaasa, Finland, explores the mechanisms that foster collaboration in the energy sector, highlighting the Vaasa region’s energy cluster as a successful example.
The transition to sustainable energy systems is one of the most pressing challenges of our time. Successfully navigating this transition requires coordinated ...
2024-12-11
The TIME is a dynamic network composed of cancer cells, immune cells, and stromal components. During the early stages of tumorigenesis, the TIME attempts to eliminate abnormal cells through immune surveillance. However, as tumors evolve, they exploit the TIME to evade immune responses and promote tumor progression. Exosomes play a central role in this transformation by transporting bioactive molecules such as proteins, lipids, and nucleic acids, thereby influencing processes like immune escape, angiogenesis, and metastasis.
HCC is particularly adept ...
2024-12-11
(Toronto, December 11, 2024) JMIR Publications is proud to announce that JMIR Aging has been accepted for inclusion in the Science Citation Index Expanded (SCIE) and the Social Sciences Citation Index (SSCI).
This accomplishment follows a selective re-evaluation process, where a limited number of Emerging Sources Citation Index (ESCI) journals were considered for inclusion. To be eligible, journals needed to rank among the top three in their respective categories based on the latest Journal Citation Reports (JCR) data. JMIR Aging’s acceptance into SCIE and SSCI underscores its exceptional quality and impact, demonstrated by its outstanding performance ...
2024-12-11
The majority of children who started smoking tobacco at age 10 years or in their later teens continued to smoke until their mid-twenties. Continuous smoking from childhood significantly increased the risk of premature heart damage, a new study shows. The study was conducted in collaboration between the Universities of Bristol and Exeter in the UK, and the University of Eastern Finland, and the results were published in the prestigious Journal of the American College of Cardiology (JACC).
In the present study, 1,931 children drawn from the University of Bristol’s Children of the 90s cohort were followed up from age 10 until 24 years. ...
2024-12-11
Cigarette smoking from childhood into early adulthood is associated with an increased risk of premature cardiac injury, according to a study published today in JACC, the flagship journal of the American College of Cardiology. This early damage to the structure and function of the heart can also significantly increase the chance of future cardiovascular (CVD) mortality in mid-life.
“Our goal is to provide data for policymakers, clinicians, and public health practitioners on crucial timing for preventing smoking and its early consequences in youth,” ...
2024-12-11
SAN ANTONIO —December 11, 2024 — Southwest Research Institute seeks support from residents or visitors of countries worldwide to assist with an international oil sampling program. Selected participants will be paid to purchase prequalified oil samples from retail stores and ship them to SwRI’s headquarters in San Antonio. Prequalification for the program will occur via an emailed photo exchange.
Participants will purchase four 1-quart or 1-liter containers, or one 1-gallon container, of specified brands ...
2024-12-11
Statistical and Engineering Approaches to Federated Learning: Comprehensive Benchmarking for Healthcare Applications
A groundbreaking study conducted by Duke-NUS Medical School evaluates federated learning (FL) methods to guide healthcare researchers in choosing privacy-preserving algorithms tailored to their clinical goals. This comprehensive benchmark compared statistical and engineering FL frameworks, offering actionable insights to balance predictive accuracy and interpretability in medical research.
Federated learning (FL) has emerged as a powerful tool in healthcare, enabling collaboration across institutions without compromising patient ...
2024-12-11
Drug addiction has been one of America’s growing public health concerns for decades. Despite the development of effective treatments and support resources, few people who are suffering from a substance use disorder seek help. Reluctance to seek help has been attributed to the stigma often attached to the condition. So, in an effort to address this problem, researchers at Drexel University are raising awareness of the stigmatizing language present in online forums and they have created an artificial intelligence tool to help educate users and offer alternative language.
Presented at the recent ...
LAST 30 PRESS RELEASES:
[Press-News.org] Breakthroughs in cell-penetrating monoclonal antibody therapies
“Monoclonal antibodies (mAb) have emerged as a promising tool in advancing personalized medicine”
